skinny.

Latest / The Best of the Money Show

Aspen reports 28% earnings growth as R28bn APAC sale strengthens balance sheet

Stephen Grootes speaks to Sean Capazorio, Aspen Group Chief Financial Officer about Aspen Pharmacare’s FY2026 results and the company’s stronger financial position after the R28 billion divestment of its APAC business. Aspen delivered 14% growth in normalised EBITDA at constant exchange rates, while normalised HEPS from continuing operations rose 28% to 801.5 cents, with the group ending the year in a net cash position of about R800 million. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.